South San Francisco Merck office in San Francisco. Photo: Jason Doiy/ALM

A federal judge in Virginia approved a $70 million settlement agreement Thursday between several municipal employee benefit funds and two pharmaceutical companies—Merck & Co. and Glenmark Pharmaceuticals – over the cholesterol-lowering medication Zetia, and allegations that drug manufacturers colluded to delay the introduction of a less-expensive generic version.

Continue Reading for Free

Register and gain access to:

  • Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
  • Educational webcasts, white papers, and ebooks from industry thought leaders
  • Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Allison Dunn

Allison Dunn is a reporter on ALM's Rapid Response desk based in Ohio, covering impactful litigation filings and rulings, emerging legal trends, controversies in the industry, and everything in between. Contact her at [email protected]. On Twitter: @AllisonDWrites.

Consumer Driven Health Care
Core and Group Health
Employee-Paid
Employer-Paid